The European Medicines Agency has assigned all its evaluators a ‘risk level’ for conflicts of interest with the pharmaceutical industry.
The agency has given a risk level between 1 and 3 to each specialist listed in its 3,500-strong register, in a bid to make its regulatory process more transparent.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.